🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the safety and efficacy of Siponimod (BAF312) versus placebo in a ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12-20
Trial ID
NCT01665144
The purpose of this study is to assess the safety, tolerability, and effect...
Status
Completed
Location
Novartis
Start Date
2006-10
Trial ID
NCT00422175
Treatments Being Tested
Collaboration with multiple sclerosis (MS) specialty colleagues led us to f...
Status
Recruiting
Location
St. Joseph's Hospital and Medical Center
Start Date
2025-08-26
Trial ID
NCT06639282
This study determined the efficacy, safety, tolerability and the PK profile...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2010-06-15
Trial ID
NCT01148810
This study investigated the dose response relationship for the efficacy and...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-08-25
Trial ID
NCT02029274
The purpose of this study was to determine the dose-response curve for the ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-03-30
Trial ID
NCT00879658
The primary goal of this study is to evaluate the effects of BAF312 (siponi...
Status
Completed
Location
Jordan Research & Education Institute: Sutter Alta Bates Summit
Start Date
2014-12
Trial ID
NCT02330965
Treatments Being Tested
This is a randomized, placebo-controlled, subject and investigator-blinded ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-12-24
Trial ID
NCT03338998
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in p...
Status
Active Not Recruiting
Location
Arkansas Childrens Hosp Rsch Inst
Start Date
2021-10-05
Trial ID
NCT04926818
Treatments Being Tested